Mount Logan Capital Valuation

Is P31Q undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of P31Q when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: P31Q (€1.28) is trading below our estimate of fair value (€10.74)

Significantly Below Fair Value: P31Q is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for P31Q?

Key metric: As P31Q is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for P31Q. This is calculated by dividing P31Q's market cap by their current revenue.
What is P31Q's PS Ratio?
PS Ratio	0.3x
Sales	US$143.07m
Market Cap	US$38.44m

P31Q key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	n/a
Enterprise Value/EBITDA	n/a
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does P31Q's PS Ratio compare to its peers?

The above table shows the PS ratio for P31Q vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	1.1x
DFTK DF Deutsche Forfait	1.9x	n/a	€17.7m
ALG ALBIS Leasing	1.5x	n/a	€58.5m
EBEN aifinyo	0.2x	n/a	€13.3m
FRS FORIS	0.5x	n/a	€12.6m
P31Q Mount Logan Capital	0.3x	n/a	€38.4m

Price-To-Sales vs Peers: P31Q is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (1.1x).

Price to Sales Ratio vs Industry

How does P31Q's PS Ratio compare vs other companies in the DE Diversified Financial Industry?

4 Companies	Price / Sales	Estimated Growth	Market Cap
Industry Avg.	1.9x	13.0%
P31Q Mount Logan Capital	0.3x	n/a	US$38.44m
EBEN aifinyo	0.3x	n/a	US$15.51m
EBEN aifinyo	0.2x	n/a	US$13.83m

4 Companies		Estimated Growth	Market Cap
Industry Avg.	1.9x	37.8%
P31Q Mount Logan Capital	0.3x	n/a	US$38.44m

No more companies

Price-To-Sales vs Industry: P31Q is good value based on its Price-To-Sales Ratio (0.3x) compared to the European Diversified Financial industry average (1.9x).

Price to Sales Ratio vs Fair Ratio

What is P31Q's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

P31Q PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.3x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate P31Q's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Yeahka

HK$4.2b

An investment holding company, provides payment and business services to merchants and consumers in the People’s Republic of China.

4YE

HK$1.19

-4.8%

-30.0%

ORIX

JP¥3.8t

Provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East.

OIX

JP¥20.20

21.0%

Mutares SE KGaA

€484.6m

A private equity firm specializing in investments in secondary direct, special situations, bridge financing, recapitalization, distressed/vulture, management succession, reorganization, carve-outs, turnarounds, spin-offs and re-funding.

MUX

€22.40

1.1%

-29.3%